Trial Profile
Lung Anatomic, Physiologic, and Inflammatory Changes With Chronic Exposure to Secondhand Tobacco Smoke
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Mar 2023
Price :
$35
*
At a glance
- Drugs Salbutamol (Primary)
- Indications Asthma; Obstructive airway disorders
- Focus Proof of concept; Therapeutic Use
- 22 Mar 2023 Planned End Date changed from 31 Dec 2022 to 31 Dec 2023.
- 22 Mar 2023 Planned primary completion date changed from 31 Dec 2022 to 31 Dec 2023.
- 22 Feb 2022 Planned End Date changed from 31 Dec 2021 to 31 Dec 2022.